Corrigendum to "Expressing IL-15/IL-18 and CXCR2 improve infiltration and survival of EGFRvIII-targeting CAR-T cells in breast cancer" biochemical pharmacology 212 (2023) 115536. PMID:37028461.

Sun Ruixin Liu Yifan Wu Chuanlong Zhou Min Luo Hong Du Guoxiu Liu Zhengyang Sun Yansha Dong Yiwei Su Jingwen Fan Mingliang Shi Bizhi Jiang Hua Li Zonghai

Biochem Pharmacol

State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200032, China; CARsgen Therapeutics, Shanghai 200032, China. Electronic address:

Published: August 2023

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.bcp.2023.115649	DOI Listing

Publication Analysis

Top Keywords

corrigendum "expressing

"expressing il-15/il-18

il-15/il-18 cxcr2

cxcr2 improve

improve infiltration

infiltration survival

survival egfrviii-targeting

egfrviii-targeting car-t

car-t cells

cells breast

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!